Cocaine in Parotid Saliva, Blood and Urine - 4

This study has been completed.

First Received on September 20, 1999. Last Updated on June 23, 2005 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	University of Pennsylvania
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000190

Purpose

The purpose of this study is to establish the use of parotid saliva as a means of detecting and quantifying cocaine and its metabolites.

Condition	Intervention	Phase
Cocaine-Related Disorders	Procedure: Parotid Gland	Phase I

Study Type:	Interventional
Study Design:	Primary Purpose: Diagnostic
Official Title:	Cocaine in Parotid Saliva, Blood and Urine

Resource links provided by NLM:

MedlinePlus related topics: Urine and Urination

Drug Information available for: Cocaine hydrochloride

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Estimated Enrollment:	0
Study Start Date:	January 1991

Eligibility

Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000190

Locations

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178

Sponsors and Collaborators

University of Pennsylvania

Investigators

Principal Investigator:

James Cornish, M.D.

University of Pennsylvania

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00000190 History of Changes
Other Study ID Numbers:	NIDA-00144-4, K20-00144-4
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on February 12, 2012